Iron overload disorders

被引:94
作者
Hsu, Christine C. [1 ]
Senussi, Nizar H. [2 ]
Fertrin, Kleber Y. [3 ]
Kowdley, Kris, V [4 ,5 ]
机构
[1] Medstar Georgetown Univ Hosp, Medstar Georgetown Transplant Inst, Washington, DC USA
[2] Univ New Mexico, Gastroenterol & Hepatol, Albuquerque, NM 87131 USA
[3] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98105 USA
[4] Washington State Univ, Liver Inst Northwest, 3216 NE 45th Pl,Suite 212, Seattle, WA 98105 USA
[5] Washington State Univ, Elson S Floyd Coll Med, 3216 NE 45th Pl,Suite 212, Seattle, WA 98105 USA
关键词
TRANSFUSION-DEPENDENT PATIENTS; FATTY LIVER-DISEASE; HEMOCHROMATOSIS GENE-MUTATIONS; SERUM FERRITIN LEVELS; MYELODYSPLASTIC SYNDROMES; HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; APLASTIC-ANEMIA; OXIDATIVE STRESS; HFE MUTATIONS;
D O I
10.1002/hep4.2012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Iron overload disorders represent a variety of conditions that lead to increased total body iron stores and resultant end-organ damage. An elevated ferritin and transferrin-iron saturation can be commonly encountered in the evaluation of elevated liver enzymes. Confirmatory homeostatic iron regulator (HFE) genetic testing for C282Y and H63D, mutations most encountered in hereditary hemochromatosis, should be pursued in evaluation of hyperferritinemia. Magnetic resonance imaging with quantitative assessment of iron content or liver biopsy (especially if liver disease is a cause of iron overload) should be used as appropriate. A secondary cause for iron overload should be considered if HFE genetic testing is negative for the C282Y homozygous or C282Y/H63D compound heterozygous mutations. Differential diagnosis of secondary iron overload includes hematologic disorders, iatrogenic causes, or chronic liver diseases. More common hematologic disorders include thalassemia syndromes, myelodysplastic syndrome, myelofibrosis, sideroblastic anemias, sickle cell disease, or pyruvate kinase deficiency. If iron overload has been excluded, evaluation for causes of hyperferritinemia should be pursued. Causes of hyperferritinemia include chronic liver disease, malignancy, infections, kidney failure, and rheumatic conditions, such as adult-onset Still's disease or hemophagocytic lymphohistiocytosis. In this review, we describe the diagnostic testing of patients with suspected hereditary hemochromatosis, the evaluation of patients with elevated serum ferritin levels, and signs of secondary overload and treatment options for those with secondary iron overload.
引用
收藏
页码:1842 / 1854
页数:13
相关论文
共 123 条
[1]   The Impact of Phlebotomy in Nonalcoholic Fatty Liver Disease: A Prospective, Randomized, Controlled Trial [J].
Adams, Leon A. ;
Crawford, Darrell H. ;
Stuart, Katherine ;
House, Michael J. ;
St Pierre, Timothy G. ;
Webb, Malcolm ;
Ching, Helena L. I. ;
Kava, Jenny ;
Bynevelt, Michael ;
MacQuillan, Gerry C. ;
Garas, George ;
Ayonrinde, Oyekoya T. ;
Mori, Trevor A. ;
Croft, Kevin D. ;
Niu, Xianwa ;
Jeffrey, Gary P. ;
Olynyk, John K. .
HEPATOLOGY, 2015, 61 (05) :1555-1564
[2]   Pathways underlying iron accumulation in human nonalcoholic fatty liver disease [J].
Aigner, Elmar ;
Theurl, Igor ;
Theurl, Milan ;
Lederer, Dieter ;
Haufe, Heike ;
Dietze, Otto ;
Strasser, Michael ;
Datz, Christian ;
Weiss, Guenter .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (05) :1374-1383
[3]   Regulation of systemic iron homeostasis: how the body responds to changes in iron demand [J].
Anderson, Gregory J. ;
Darshan, Deepak ;
Wilkins, Sarah J. ;
Frazer, David M. .
BIOMETALS, 2007, 20 (3-4) :665-674
[4]   Iron absorption and metabolism [J].
Anderson, Gregory J. ;
Frazer, David M. ;
McLaren, Gordon D. .
CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (02) :129-135
[5]  
Angelucci E, 2020, ANN INTERN MED, V173, P595, DOI 10.7326/L20-1056
[6]   Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial) [J].
Angelucci, Emanuele ;
Santini, Valeria ;
Di Tucci, Anna Angela ;
Quaresmini, Giulia ;
Finelli, Carlo ;
Volpe, Antonio ;
Quarta, Giovanni ;
Rivellini, Flavia ;
Sanpaolo, Grazia ;
Cilloni, Daniela ;
Salvi, Flavia ;
Caocci, Giovanni ;
Molteni, Alfredo ;
Vallisa, Daniele ;
Voso, Maria Teresa ;
Fenu, Susanna ;
Borin, Lorenza ;
Latte, Giancarlo ;
Alimena, Giuliana ;
Storti, Sergio ;
Piciocchi, Alfonso ;
Fazi, Paola ;
Vignetti, Marco ;
Tura, Sante .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) :527-536
[7]   Massive iron overload and acute-on-chronic liver failure in a patient with Diamond-Blackfan anaemia: a case report [J].
Assis-Mendonca, Guilherme Rossi ;
Cunha-Silva, Marlone ;
Fernandes, Mariana Franson ;
Torres, Luiza Dias ;
de Almeida Verissimo, Monica Pinheiro ;
Neves Okano, Marcelo Trevisan ;
Mazo, Daniel Ferraz ;
Lalli, Cristina Alba ;
Seva-Pereira, Tiago ;
Stelini, Rafael Fantelli ;
Eloy da Costa, Larissa Bastos .
BMC GASTROENTEROLOGY, 2020, 20 (01)
[8]   Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study [J].
Aydinok, Yesim ;
Porter, John B. ;
Piga, Antonio ;
Elalfy, Mohsen ;
El-Beshlawy, Amal ;
Kilinc, Yurdanur ;
Viprakasit, Vip ;
Yesilipek, Akif ;
Habr, Dany ;
Quebe-Fehling, Erhard ;
Pennell, Dudley J. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) :244-253
[9]   Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases [J].
Bacon, Bruce R. ;
Adams, Paul C. ;
Kowdley, Kris V. ;
Powell, Lawrie W. ;
Tavill, Anthony S. .
HEPATOLOGY, 2011, 54 (01) :328-343
[10]   Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease [J].
Badawy, Sherif M. ;
Liem, Robert I. ;
Rigsby, Cynthia K. ;
Labotka, Richard J. ;
DeFreitas, R. Andrew ;
Thompson, Alexis A. .
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (04) :705-713